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Abstract Apoptosis is coupled with recruitment of macrophages for engulfment of dead cells, 
and with compensatory proliferation of neighboring cells. Yet, this death process is silent, and it 
does not cause inflammation. The molecular mechanisms underlying anti-inflammatory nature of the 
apoptotic process remains poorly understood. In this study, we found that the culture supernatant 
of apoptotic cells activated the macrophages to express anti-inflammatory genes such as Nr4a and 
Thbs1. A high level of AMP accumulated in the apoptotic cell supernatant in a Pannexin1-dependent 
manner. A nucleotidase inhibitor and A2a adenosine receptor antagonist inhibited the apoptotic 
supernatant-induced gene expression, suggesting AMP was metabolized to adenosine by an 
ecto-5’-nucleotidase expressed on macrophages, to activate the macrophage A2a adenosine 
receptor. Intraperitoneal injection of zymosan into Adora2a- or Panx1-deficient mice produced 
high, sustained levels of inflammatory mediators in the peritoneal lavage. These results indicated 
that AMP from apoptotic cells suppresses inflammation as a ‘calm down’ signal.
DOI: 10.7554/eLife.02172.001
Introduction
Approximately, 100,000 cells undergo apoptosis every second in our bodies, and are engulfed by mac-
rophages and immature dendritic cells (Fuchs and Steller, 2011). Inefficient clearance of apoptotic cells 
causes systemic lupus erythematosus (SLE)-type autoimmune disease in humans and mice (Botto et al., 
1998; Hanayama et al., 2004; Munoz et al., 2010). Apoptotic cells characteristically expose ‘eat me’ 
signal(s) to macrophages (Nagata et al., 2010; Ravichandran, 2011), and one of the primary ‘eat me’ 
signals is phosphatidylserine (PtdSer). PtdSer is a phospholipid that localizes to the inner leaflet of plasma 
membranes in healthy cells; however, when cells undergo apoptosis, it is exposed on the outer cell sur-
face in a caspase-dependent manner (Fadok et al., 2001; Leventis and Grinstein, 2010; Suzuki et al., 
2013). Macrophages express membrane proteins that function as receptors for PtdSer (e.g., Tim-4, 
stabllin 2, and BAI1), or opsonins that bind to PtdSer (e.g. MFG-E8, Protein S, and Gas6) (Nagata et al., 
2010). Masking the PtdSer on apoptotic cells prevents their engulfment by macrophages, supporting 
the idea that PtdSer is an important ‘eat me’ signal.
Apoptotic cells also produce ‘find me’ signals to attract macrophages (Ravichandran, 2011). 
Lysophosphatidylcholine (LPC) (Lauber et al., 2003), ATP/UTP (Elliott et al., 2009), fractalkine (Truman 
et al., 2008), and sphingosine-1-phosphate (S1P) (Gude et al., 2008) are released from apoptotic cells 
in a caspase-dependent manner. Macrophages express specific receptors for these signals (P2Y2 for 
ATP and UTP, CX3CR1 for fractalkine, and S1PR1 for S1P), which may mediate migration to the dying 
*For correspondence: snagata@
mfour.med.kyoto-u.ac.jp
Present address: †Molecular 
Sleep Biology Laboratory, 
WPI-International Institute for 
Integrative Sleep Medicine, 
University of Tsukuba, Ibaraki, 
Japan
Competing interests: The 
authors declare that no 
competing interests exist.
Funding: See page 12
Received: 27 December 2013
Accepted: 11 February 2014
Published: 25 March 2014
Reviewing editor: David 
Wallach, Weizmann Institute, 
Israel
 Copyright Yamaguchi et al. 
This article is distributed under 
the terms of the Creative 
Commons Attribution License, 
which permits unrestricted use 
and redistribution provided that 
the original author and source 
are credited.
RESEARCH ARTICLE
Cell biology | Immunology
Yamaguchi et al. eLife 2014;3:e02172. DOI: 10.7554/eLife.02172 2 of 15
Research article
cells (Ravichandran, 2011). The ‘find me’ signals are thought to prime macrophages for engulfment, 
for example by enhancing the expression of MFG-E8 (Miksa et al., 2007). On the other hand, LPC, 
ATP/UTP, and S1P are known to cause inflammation (Trautmann, 2009; Maceyka et al., 2012; Meyer 
zu Heringdorf and Jakobs, 2007), which may contradict the anti-inflammatory nature of the apop-
totic process. In addition, several groups showed that apoptotic cells produce growth-stimulating 
molecules such as Wnt3 or prostaglandin E2 (Chera et al., 2009; Huang et al., 2011; Mollereau 
et al., 2013), which is also against the silent nature of the process. Thus, how the anti-inflammatory 
character of the apoptosis is maintained during the process has been unclear.
In this study, we found that soluble factors derived from the apoptotic cells activated macrophages to 
express immediate early response genes including anti-inflammatory genes such as Nuclear receptor 4A 
(Nr4a) and Thrombospondin (Thbs)1. Using Thbs1 gene expression as a marker, the molecule respon-
sible for the gene expression was identified as AMP. The overexpression of Pannexin 1 in apoptotic 
cells accelerated the accumulation of AMP in the culture supernatant of apoptotic cells, while a cas-
pase-resistant form of Pannexin 1 inhibited the AMP accumulation. An inhibitor of ecto-5′-nucleotidase 
blocked the AMP-induced activation of the Thbs1 gene in macrophages, while macrophages from 
A2a adenosine receptor (Adora2a)-deficient mice did not respond to AMP. These results indicated 
that AMP from apoptotic cells was converted to adenosine by an ecto-5′-nucleotidase on macro-
phages, and that the adenosine activated a set of genes in macrophages via the A2a adenosine 
receptor. Mice deficient in Adora2a or Panx1 exhibited prolonged peritonitis following intraperi-
toneal zymosan injection, suggesting that the AMP released from apoptotic peritoneal cells exerted 
an anti-inflammatory effect by activating the A2a adenosine receptor.
Results
Gene expression in macrophages by a factor released from apoptotic 
cells
If apoptotic cells produce ‘danger’ or ‘anti-danger’ signal(s), we rationalized that such signals 
would activate gene expression in macrophages. To investigate this possibility, we examined the 
effect of the culture supernatant from apoptotic cells on macrophage gene expression. Mouse WR19L 
transformants expressing Fas (W3 cells) were treated with Fas ligand (FasL) for 30 min, washed, and 
then further incubated for 60 min. Following FasL treatment, more than 90% of the W3 cells were 
eLife digest Infections, toxins, and trauma can all injure tissue and cause the cells inside the 
tissue to die. When a cell dies, the membrane that surrounds it ruptures and its contents spill out, 
triggering inflammation of the surrounding tissues. This inflammation is part of the body’s efforts to 
begin the healing process but, if left uncontrolled, inflammation itself can cause further tissue 
damage.
Diseased or damaged cells can also ‘choose’ to kill themselves to protect other healthy cells. 
This process, which is called apoptosis, also eliminates about 100,000 cells that are too old, or just 
no longer needed, from the human body every second. A cell undergoing apoptosis essentially 
dismantles itself, and the remains of the cell are packaged up, and cleared away by the white blood 
cells. Interestingly, this programed cell death releases many of the same molecules as other dying 
cells, but does so without triggering inflammation. The reason behind this lack of inflammation has 
not been clear.
Now, Yamaguchi et al. have addressed this issue, and shown that cells undergoing apoptosis also 
release a chemical called adenosine monophosphate (AMP) that acts as a ‘calm down’ signal. The 
AMP is processed by white blood cells to a simpler chemical, which ‘switches on’ various genes in 
the white blood cells. This leads to the production of proteins that suppress the inflammation that 
would otherwise be triggered by other molecules released from the cells undergoing apoptosis. 
The findings of Yamaguchi et al. show how the community of cells in our body is kept in a healthy 
balance, and in the future, could improve our understanding and the treatment of inflammatory 
diseases.
DOI: 10.7554/eLife.02172.002
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Annexin V positive, and only small percentage were positive for both Annexin V and propidium iodide 
(PI) (Figure 1—figure supplement 1), indicating that the majority of cells had undergone apoptosis 
but not necrosis. Mouse bone marrow-derived macrophages (BMDMs) were then incubated for 1 hr 
with the supernatant of FasL-treated W3 cells, and subjected to microarray analysis. As shown in 
Figure 1A, the mRNA levels of N-myc (Mycn), Nr4a orphan nuclear receptor family members, Egr 
transcription factors (Egr2 and Egr3), Thrombospondin 1 (Thbs1), and Il-1β were 15- to 200-fold higher 
in the macrophages treated with apoptotic cell supernatant than in the control, untreated macrophages. 
A real-time RT-PCR analysis confirmed that the supernatants of apoptotic cells but not of healthy cells 
strongly induced the expression of Nr4a1, Nr4a2, and Thbs1 (Figure 1B). When W3 cells were treated 
with FasL in the presence of Q-VD-OPh, a caspase inhibitor (Caserta et al., 2003), the ability of the 
supernatant to upregulate the Thbs1 gene was abrogated, indicating that the factor(s) responsible for 
upregulating Thbs1 gene were generated in a caspase-dependent manner (Figure 1C). Thbs1 and 
Nr4a are known to suppress inflammation (Lopez-Dee et al., 2011; McMorrow and Murphy, 2011), 
and a danger signal such as ATP is unlikely to activate these genes.
Treatment of the apoptotic cell supernatant with proteinase K (50 μg/ml for 60 min), DNase I (6 U/ml 
for 60 min), or RNase A (5 μg/ml for 60 min) did not prevent its ability to enhance Thbs1 gene expression 
(Figure 1D), suggesting that the factor(s) were not proteins or polynucleotides. When the supernatant 
was subjected to centrifugal ultrafiltration with a filter with a nominal cutoff of 10 kDa, most of the activity 
was found in the filtrate, and not in the concentrate (Figure 1E). These results indicated that the molec-
ular weight of the factor(s) that activated the macrophages were less than 10 kDa, and may have been 
present as a free form.
Identification of AMP as a factor that stimulates gene expression in 
macrophages
To identify the molecule(s) present in the apoptotic cell supernatant, the supernatant was subjected to 
LC-MS analysis. As shown in Figure 2A, various nucleotides and nucleosides such as AMP, UMP, cyti-
dine, inosine, hypoxanthine, and uridine were present in the FasL-treated cell supernatant.
To examine which molecule(s) in the apoptotic cell supernatant were responsible for the enhanced 
Thbs1 gene expression, macrophages were incubated with the various compounds found in the 
apoptotic cell supernatant at 10 μM. The results indicated that AMP, but none of other nucleosides 
or nucleotides, activated macrophages (Figure 2B). Apyrase, an enzyme that catalyzes the hydrol-
ysis of ATP to AMP, had no effect on the apoptotic cell supernatant activity, indicating that the 
factor was not ATP or ADP (Figure 2C). In contrast, adenosine-5’-O-(α, β- methylenediphosphate) 
(AOPCP), a non-hydrolyzable ADP analog that inhibits the ecto-5′-nucleotidase, blocked the Thbs1 
gene expression induced by the apoptotic cell supernatant (Figure 2C), indicating that adenosine, 
but not AMP, is responsible for activation of the Thbs1 gene in macrophages. Treatment of the 
apoptotic cell supernatant with adenosine deaminase (ADA), that converts adenosine to inosine 
abrogated its ability to activate Thbs1 gene expression (Figure 2C), confirming that adenosine was 
responsible for the activity. Accordingly, treating BMDMs with adenosine activated the Thbs1 gene in 
a dose-dependent manner (Figure 2D). Since adenosine was undetectable in the supernatant of 
the FasL-treated W3 cells, we concluded that AMP in the supernatant of these cells was converted 
to adenosine by the ecto-5′-nucleotidase expressed on macrophages, resulting in the stimulation 
of gene expression in macrophages.
Extracellular adenosine is recognized by the G-protein coupled adenosine receptor family (Fredholm, 
2007). A real-time RT-PCR analysis indicated that BMDMs and thioglycollate-elicited peritoneal 
macrophages (thio-pMacs) did not express A1 or A3 adenosine receptor (Adora1 or Adora3), but 
predominantly expressed the A2b and A2a receptors (Adora2b and Adora2a), respectively (Figure 2E). 
Accordingly, an A2b antagonist (alloxazine) inhibited the apoptotic cell supernatant-induced Thbs1 
gene expression in BMDMs, but only weakly inhibited the induced Thbs1 gene expression in thio-
pMacs (Figure 2F). An A2a antagonist (SCH58261) had an inhibitory effect on thio-pMacs, but not 
on BMDMs, whereas antagonists of A1 (DPCPX) and A3 (VUF5574) had no effect on thio-pMacs or 
BMDMs. Adora2a−/− thio-pMacs lost their ability to upregulate the expression of Nr4a1 and Thbs1 
genes in response to the apoptotic cell supernatant (Figure 2G), confirming the essential role of the 
A2a receptor in this process. These results confirmed that adenine nucleotides released from apop-
totic cells were converted to adenosine, which in turn activated macrophages by binding to aden-
osine receptors.
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Figure 1. Factor(s) released from apoptotic cells stimulate gene expression in macrophages. (A and B) BMDMs 
were incubated for 1 hr with medium or with the supernatant of W3 cells that had been treated with (apoptotic) or 
without (living) 30 units/ml FasL. RNA from BMDMs was then subjected to microarray analysis. (A) Genes whose 
expression was upregulated more than 10-fold after incubation with the apoptotic cell supernatant are listed. 
(B) Nr4a1, Nr4a2, and Thbs1 mRNA levels were quantified by real-time RT-PCR, and normalized to Gapdh mRNA. 
(C) W3 cells were pre-treated with or without 20 μM Q-VD-OPh for 20 min and stimulated with or without 30 units/ml 
FasL. BMDMs were then incubated for 1 hr with the supernatant of Q-VD-OPh-treated (+) or untreated (−) living or 
FasL-treated apoptotic W3 cells, and Thbs1 mRNA levels were determined by real-time RT-PCR. (D) BMDMs were 
incubated with the supernatant of apoptotic W3 cells that had been treated with proteinase K (proK), DNase I or 
RNase A, and Thbs1 mRNA levels were determined. (E) Medium, the culture supernatant of healthy W3 cells (living) 
or apoptotic W3 cells (apop) were subjected to ultrafiltration through a 10 kDa-cutoff filter, and the filtrate (<10 kDa) 
and concentrate (>10 kDa) were tested for their ability to induce Thbs1 expression in BMDMs. Experiments were 
performed in triplicates, and the average values are plotted with SD (bars). All experiments were repeated at least 
twice with BMDM from different mice, and representative data are shown.
DOI: 10.7554/eLife.02172.003
The following figure supplements are available for figure 1:
Figure supplement 1. FasL-induced apoptosis in W3 cells. 
DOI: 10.7554/eLife.02172.004
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Caspase-dependent accumulation of AMP
Apoptotic cells are reported to release ATP (Elliott et al., 2009), and AMP can be generated from ATP 
by ectonucleotide pyrophosphatase/phosphodiesterase (E-NTPDase) (Bours et al., 2006). To examine 
whether these events were involved in the apoptotic supernatant activity, the release of adenine nucle-
otides from apoptotic cells was followed over time. W3 cells were treated with FasL, and aliquots of 
the culture supernatant were collected at different time points and analyzed by LC-MS. As shown in 
Figure 3A, healthy cells secreted low levels of AMP, whereas FasL-induced apoptosis caused a gradual 
increase of AMP in the supernatant. At 2 hr after the addition of FasL, the AMP level had increased to 
more than 4 μM in a culture of 1.0 × 107 cells/ml. The concentration of ADP also increased, but was 
less pronounced compared with that of AMP. In contrast, at 2 hr the concentration of ATP was substan-
tially lower, 40 nM or 40 pmoles per 107 cells. In various apoptosis systems, the intracellular ATP level 
is reported to remain high (Eguchi et al., 1997; Bossy-Wetzel et al., 1998). However, the intracellular 
concentration of ATP in the FasL-treated W3 cells rapidly decreased, whereas the concentrations of 
ADP and AMP concomitantly increased (Figure 3B), suggesting that AMP was directly released from 
apoptotic cells. Exogenously added ATP was slowly degraded in the supernatant of FasL-treated W3 
cells (Figure 3—figure supplement 1) providing additional support that AMP was released directly 
Figure 2. Identification of the factor in apoptotic cell supernatant that stimulates macrophage gene expression. (A) The supernatant of apoptotic 
W3 cells was subjected to LC-MS analysis. The relative concentration of each compound is represented by the base peak intensity. (B) BMDMs 
were incubated with medium containing 10 μM of the indicated reagents for 1 hr, and Thbs1 mRNA levels were determined by real-time RT-PCR. 
(C) Apoptotic W3 cell supernatant was pretreated with 25 mU/ml apyrase at 37°C for 1 hr. BMDMs were incubated for1 hr with the pretreated or 
untreated supernatant, and the Thbs1 mRNA levels were determined. BMDMs were also treated with the supernatant in the presence of 10 μM 
AOPCP or 0.9 U/ml adenosine deaminase (ADA), and the Thbs1 mRNA levels were quantified as above. (D) BMDMs were incubated with apop-
totic cell supernatant (apop) or medium supplemented with the indicated concentrations of adenosine (Ado), and the Thbs1 mRNA levels were 
determined. (E) The mRNA levels of the Adora1, Adora2a, Adora2b, and Adora3 expressed in BMDMs and thio-pMacs were determined by real-time 
RT-PCR, and normalized to β-actin mRNA. (F) BMDMs and thio-pMacs were incubated with W3 apoptotic cell supernatant and adenosine receptor 
antagonists, 5 nM 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) (A1), 10 nM SCH58261 (A2a), 5 μM alloxazine (A2b), or 130 nM VUF5574 (A3), and 
Thbs1 mRNA levels were determined. (G), Thio-pMacs from Adora2a+/+ (control) or Adora2a−/− mice were incubated with medium, apoptotic or 
living W3 cell supernatants, and the Nr4a1 and Thbs1 mRNA levels were determined by real-time RT-PCR. Experiments were performed in triplicate, 
and the average values are plotted with SD (bars). All experiments were repeated at least twice with BMDM or thio-pMacs from different mice, 
and representative data are shown.
DOI: 10.7554/eLife.02172.005
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from the apoptotic cells, and not extracellularly converted from ATP. When mouse thymocytes in a 
culture of 1 × 108 cells/ml were treated with FasL for 90 min to induce apoptosis in approximately 70% 
of the cells (8% were PI positive), the culture supernatant was found to contain 3.5 μM AMP, whereas 
the supernatant of healthy cells cultured for 1 hr contained approximately 0.2 μM AMP (Figure 3C). 
Consistent with our finding using W3 cells, the levels of ATP and ADP in the FasL-treated thymocyte 
were 40 and 100 times lower than that of AMP, respectively. These results further suggest that AMP 
was directly released from primary thymocytes undergoing apoptosis.
Pannexin 1-dependent release of AMP from apoptotic cells
The AMP release from FasL-treated W3 cells was suppressed by a caspase inhibitor, Q-VD-OPh, in a 
dose-dependent manner (Figure 4A). Chekeni et al. (2010) reported that Pannexin 1 is cleaved by 
caspase in apoptotic cells and mediates the release of ATP from these cells. Pannexins are a family of 
plasma membrane channel proteins consisting of 3 members (Baranova et al., 2004). W3 cells and 
thymocytes expressed Panx1, but not Panx2 or Panx3 (Figure 4—figure supplement 1). A synthetic 
derivative of glycyrrhetinic acid (CBX, carbenoxolone), an inhibitor of Pannexin and Connexin channels 
(D’Hondt et al., 2009), inhibited the release of adenine nucleotides (AMP, ADP, and ATP) from FasL-
treated W3 cells, whereas gadolinium chloride (GdCl3), an inhibitor of the maxi-anion channel, failed 
Figure 3. Release of adenine nucleotides from apoptotic cells. (A and B) W3 cells were treated with (●,■,▲) or 
without (○,□,△) 120 units/ml FasL, and the concentrations of AMP (○,●), ADP (□,■) and ATP (△,▲) in the supernatant 
(A) and cells (B) were determined by LC-MS or HPLC analysis at the indicated times. (C) Mouse thymocytes were 
treated with (+) or without (−) 120 units/ml FasL for 90 min, and the concentrations of AMP, ADP, and ATP in the 
supernatants were determined. Experiments were performed in triplicate, and the average values are plotted with 
SD (bars). The treatment of cells with FasL and quantification of adenine nucleotides were repeated at least twice, 
and representative data are shown.
DOI: 10.7554/eLife.02172.006
The following figure supplements are available for figure 3:
Figure supplement 1. Minimal degradation of ATP in the apoptotic cell supernatant. 
DOI: 10.7554/eLife.02172.007
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to inhibit their release from the apoptotic cells (Figure 4A). Mouse Pannexin 1 contains a caspase 
3 recognition sequence (Asp-Ile-Ile-Asp) at amino acids 375 to 378. Therefore, we established W3 
cells expressing wild-type or caspase-resistant Pannexin1 (Figure 4—figure supplement 2). As shown 
in Figure 4B, W3 transformants expressing wild-type Pannexin 1 released significantly higher lev-
els of adenine nucleotides than the parental W3 cells upon FasL treatment. The caspase 3 recog-
nition sequence of Pannexin 1 was then mutated to a caspase-resistant sequence (Ala-Ile-Ile-Ala). 
When W3 cells were transformed with the caspase-resistant form of Pannexin 1, the transformants 
completely lost their ability to release adenine nucleotides following FasL treatment (Figure 4B), 
indicating that the caspase cleavage of Pannexin 1 was required for the release of adenine nucleotides. 
Co-culturing BMDM with FasL-treated W3 cells upregulated the Thbs1 gene expression in BMDMs 
(Figure 4C), this was not observed when the W3 cells were transformed with the caspase-resistant form 
of pannexin1. Furthermore, Panx1−/− thymocytes exhibited reduced AMP release following FasL treat-
ment compared with similarly treated wild-type thymocytes (Figure 4D). Incomplete inhibition of the 
AMP release by the Panx1−/− thymocytes may have been due to the expression of connexins in mouse 
thymocytes, or because a significant fraction of the thymocytes had undergone secondary necrosis 
(data not shown). These results indicated that caspase activation resulted in the opening of Pannexin 1 
channels, leading to AMP release.
Figure 4. Pannexin 1-dependent release of adenine nucleotides from apoptotic cells. (A) After pre-treatment with the indicated concentrations of 
Q-VD-OPh (QVD), carbenoxolone (CBX), or GdCl3 for 20 min, W3 cells were incubated with 120 units/ml FasL for 90 min. The AMP, ADP, and ATP 
concentrations in the supernatants were determined by LC-MS. (B) W3 cells transformed with empty pMXs vector (■,□), or with vectors bearing wild-type 
(wt) (●,○) or caspase-resistant mutant (mt) (▲,△) Pannexin 1 were treated (■,●,▲) or not treated (□,○,△) with 120 units/ml FasL, and the concentra-
tions of adenine nucleotides in the supernatants were determined at the indicated times. (C) The parental W3 cells (wt) and W3 cell transformants 
expressing caspase-resistant form of pannexin 1 (mt) were treated with 30 units/ml FasL for 30 min, added to BMDMs, and incubated for 1 hr. The 
Thbs1 mRNA level in BMDMs was then determined by real-time RT-PCR. (D) Thymocytes from Panx1+/+ or Panx1−/− mice were incubated with (+) 
or without (−) 120 units/ml FasL, and the concentration of adenine nucleotides in the supernatants were determined at the indicated times. Experiments 
were performed in triplicate, and the average values are plotted with SD (bars). All experiments were repeated at least twice, and the representa-
tive data are shown.
DOI: 10.7554/eLife.02172.008
The following figure supplements are available for figure 4:
Figure supplement 1. Panx mRNA expression in W3 cells and mouse thymocytes. 
DOI: 10.7554/eLife.02172.009
Figure supplement 2. Expression of wild-type and caspase-resistant Pannexin 1 in W3 cell transformants. 
DOI: 10.7554/eLife.02172.010
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Adenosine-mediated immunosuppression
The above results suggested that the AMP released from apoptotic cells is converted to adenosine by 
macrophages, and stimulates a set of genes in macrophages via activation of adenosine receptor. 
Among adenosine receptors, the A2 receptors are known to exert an anti-inflammatory effect on mac-
rophages (Sitkovsky and Ohta, 2005). To confirm that AMP could exert a similar effect on macro-
phages, mouse resident peritoneal macrophages were treated with zymosan, a glucan that stimulates 
macrophages via TLR2 (Takeuchi et al., 1999), in the presence or absence of AMP. As shown in Figure 5A, 
zymosan-stimulated macrophages to produce TNFα, a classic pro-inflammatory cytokine, and MIP-2 
(CXCL-2), a critical chemokine for neutrophil migration. The production of these factors was significantly 
suppressed by the presence of AMP.
We next examined the role of AMP secretion from apoptotic cells using the zymosan-induced 
peritonitis model (Cash et al., 2009). 3 hr after the injection of zymosan particles into the mouse 
peritoneal cavity, 30% of the peritoneal cells were Ly6B.2 and Ly6G double positive, and 20% of the 
double-positive cells were Annexin V positive, indicating that neutrophils had infiltrated into the 
cavities and undergone apoptosis (Figure 5B). 2 hr after the injection of zymosan-particles, the levels 
of TNFα and MIP-2 in the peritoneal lavage were comparable between the wild-type and Panx1−/− 
mice. However, by 6 hr the levels of these inflammatory mediators in the peritoneal cavity remained 
high in Panx1−/− mice, but had returned to normal in the wild-type mice (Figure 5C). These results 
indicated that Pannexin 1 was required to quickly resolve the zymosan-induced peritonitis. Consistent 
with the results from Panx1−/− mice, the levels of inflammatory mediators in Adora2a−/− peritoneal lavage 
fluids were greater than those in the Adora2a+/+ or Adora2a+/− lavage at 6 hr after zymosan injection 
(Figure 5D). Taken together, these results suggested that apoptotic neutrophils released adenosine 
nucleotides, most likely AMP, through Pannexin 1 channels during acute peritoneal inflammation. The 
secreted AMP was, in turn, converted to adenosine by macrophages, leading to the activation of 
adenosine A2a receptor and the upregulation of Nr4a and Thbs1 gene expression, ensuring the rapid 
resolution of peritonitis.
Discussion
Adenine nucleotides act not only as intracellular energy carriers but also as extracellular signaling 
molecules (Bours et al., 2006). For instance, extracellular ATP regulates the microglial response to 
brain injury via P1 or P2 purinergic receptors (Davalos et al., 2005), and adenosine modulates sleep–
wake cycles via A2a adenosine receptor (Urade et al., 2003). Although the release of adenine 
nucleotides mainly occurs by exocytosis (Pascual et al., 2005), it is also mediated by transport via 
channel proteins. Connexins, which form gap junctions, can serve as hemichannels, and allow ATP 
to exit (Cotrina et al., 1998; Spray et al., 2006). Pannexins, which carry 4 transmembrane regions 
with intracellular N- and C-terminal tails, are structurally similar to connexins and also form hemichan-
nels (Yen and Saier, 2007). Various physiological and pathological stimuli such as Ca2+-influx, shear 
stress, and apoptotic cell death, can cause Pannexin 1 channels to open, allowing the passage of 
molecules smaller than 1.0 kDa (D’Hondt et al., 2009). Chekeni et al. (2010) recently showed that in 
the early stages of apoptosis, caspases cleave Pannexin 1 resulting in the release of ATP, which can 
serve as a ‘find me’ signal to attract macrophages.
In this study, we found that AMP was present at 30- to 100-fold higher concentrations than ATP in 
the culture supernatants of apoptotic thymocytes and a T cell line. The ATP concentration in healthy 
cells is approximately 10–50 times higher than that of AMP. However, when cells undergo apoptosis, 
ATP is quickly hydrolyzed to AMP, while its generating system is inactivated by caspases (Ricci et al., 
2004). The caspase-cleaved Pannexin channel also contributes to the cellular loss of ATP by allowing 
ATP to exit cells through the plasma membrane. Thus, the AMP found in apoptotic cell supernatants 
could have been extracellularly converted from ATP by E-NTPDase. However, the ability of apoptotic 
or healthy W3 cell supernatants to hydrolyze ATP was very low, suggesting that E-NTPDase was not 
responsible for the accumulation of AMP in the apoptotic cell supernatants. Thus, it is possible that 
AMP generated intracellularly in apoptotic cells was released from through these channels.
The engulfment of apoptotic cells is a silent process that does not activate inflammation (Nagata 
et al., 2010; Ravichandran, 2011). Since macrophages ingesting apoptotic cells produce TGFβ or 
IL-10 that inhibits the production of inflammatory cytokines (Voll et al., 1997; Fadok et al., 1998; 
Lucas et al., 2006), this interaction and/or engulfment was thought to be responsible for the 
Cell biology | Immunology
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anti-inflammatory effect. Furthermore, Köröskényi et al. (2011) recently reported that macrophages 
engulfing apoptotic cells released adenosine to suppress inflammation. In contrast, we show here that 
apoptotic cells secrete AMP, which is converted to adenosine, resulting in macrophage activation via 
Figure 5. Immunosuppressive function of Pannexin 1 and A2a adenosine receptor in a mouse peritonitis model. 
(A) Mouse resident peritoneal macrophages were incubated with 50 μg/ml zymosan A in the presence (+) or 
absence (−) of 100 μM AMP for 16 hr. The TNFα and MIP-2 levels in the culture supernatant were determined in 
triplicate by ELISA, and the average values are plotted with S.D. (bars). The experiments were performed at least 
twice, and representative data are shown. (B) Peritoneal cells were collected at 3 hr after the injection of zymosan 
A (250 mg/kg), and stained with anti-Ly6B.2 and anti-Ly6G antibodies (left panel). Some of the Ly6B.2 and Ly6G 
double-positive cells (circled in the left panel) were stained with Cy5-labeled Annexin V (right panel). (C and D) 
After zymosan injection, peritoneal lavage fluid was collected at 2 hr (n = 5) or 6 hr (n = 7) of Panx1+/+, and at 2 hr 
(n = 5) or 6 hr (n = 10) of Panx1−/− littermates (C), or 2 hr (n = 10) or 6 hr (n = 6) of Adora2a+/+ or +/−, and at 2 hr 
(n = 8) or 6 hr (n = 6) of Adora2a−/− mice (D). The TNFα and MIP-2 levels in the fluids were determined by ELISA. 
The Student’s t test was used for the statistical analysis, and the p values are shown.
DOI: 10.7554/eLife.02172.011
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adenosine receptors, followed by the upregulation of Thbs1 and Nr4a gene expression. When the 
apoptotic cells could not release AMP due to the expression of caspase-resistant form of pannexin 1, 
the Thbs1 gene expression was not up-regulated. Furthermore, the AMP released from the resident 
peritoneal macrophages engulfing apoptotic cells was significantly smaller than that released from 
apoptotic cells (HY, and SN, data not shown). These results suggest that the contribution of the inter-
action of apoptotic cells with macrophages to anti-inflammatory effect may not be great. Thbs1 is the 
major activator of TGFβ (Crawford et al., 1998), whereas Nr4a family members inhibit the expression 
of proinflammatory cytokines such as TNFα, IL-8, and IL-6 in macrophages (Bonta et al., 2006), by 
recruiting a repressor complex to their promoter (Saijo et al., 2009). Thus, this may be one mechanism 
that suppresses inflammation during the apoptosis process.
The conversion of AMP to adenosine is catalyzed by CD73, an ecto-5’-nucleotidase, expressed on 
the surface of endothelial and immune cells (Deaglio and Robson, 2011). CD73-null mice spontane-
ously develop autoimmune diseases such as glomerulitis and peritubular capillaritis, accompanied by 
enhanced inflammation (Blume et al., 2012). They are also susceptible to polymicrobial sepsis induced 
by cecal ligation and puncture, and exhibit increased mortality and systemic inflammation (Hasko 
et al., 2011). Our results suggest that the substrate for CD73 in these models may be AMP released 
from apoptotic cells. If AMP cannot be converted to adenosine in the absence CD73, then activa-
tion of the immune system in response to the ‘danger signal(s)’ released from apoptotic cells would 
not be opposed.
We conclude that apoptotic cells themselves contribute to the ‘anti-inflammatory’ nature of the 
engulfment process by secreting AMP as an immunosuppressive ‘calm-down’ signal. Depending 
on the types of cells and apoptotic stimuli, intracellular ATP levels remain high (Bossy-Wetzel et al., 
1998; Eguchi et al., 1997; Zamaraeva et al., 2005) or rapidly decreases (Gleiss et al., 2002; Vander 
Heiden et al., 1999) during apoptosis. It will be interesting to study whether this mechanism impacts 
various types of inflammation that are accompanied by apoptosis.
Material and methods
Mice and reagents
C57BL/6J mice were purchased from Japan SLC. Adenosine receptor A2a (Adora2a) knockout mice 
(Chen et al., 1999) were from Dr Jian-Fan Chen (Boston University School of Medicine). Pannexin 1 
knockout mice (Panx1tm1a(KOMP)Wtsi) were purchased from the University of California at Davis’ KOMP 
Repository (http://www.komp.org/). All mice were housed in a specific pathogen-free facility at 
Kyoto University, Graduate School of Medicine. The committee of Kyoto University, Graduate School 
of Medicine, approved our study (Reference Number: Med Kyo 12,107). The leucine-zipper tagged 
soluble human Fas ligand (FasL) was prepared as described previously (Shiraishi et al., 2004). One 
unit of FasL was defined as the dilution that gives a half-maximum response with W3 cells, mouse 
WR19L cells expressing mouse Fas (Watanabe-Fukunaga et al., 1992).
Adenosine deaminase, apyrase, DNase I, RNase A and proteinase K were purchased from 
Calbiochem (Germany), New England BioLabs (Ipswich, MA), Takara Bio (Japan), Ambion (Austin, TK), 
and Merck (Germany), respectively. A caspase inhibitor, N-(2-Quinolyl)valyl-aspartyl-(2,6-difluorophenoxy)
methyl Ketone (Q-VD-OPh) was from R&D Systems (Minneapolis, MN). Adenosine, AMP, ADP, and 
ATP were from Nacalai (Japan). Cytidine, inosine, guanine, hypoxanthine, uridine, guanosine, taurine, 
UMP, CDP-choline CMP, and α, β-methyleneadenosine 5′-diphosphate (AOPCP) were from Sigma 
(St. Louis, MO). Antagonists for A1 (8-cyclopentyi-1,3-dipropylxanthine), A2a (SCH58261), A2b (Alloxazine), 
and A3 Adenosine receptor (VUF5574) were from Sigma. Carbenoxolone, an inhibitor of Pannexin 
channel, was purchased from Sigma. Gadolinium chloride hexahydrate (GdCl3.6H2O), an inhibitor of 
maxi anion channel, was from Aldrich (St. Louis, MO).
Preparation of macrophages
For mouse bone marrow-derived macrophages (BMDMs), bone marrow cells from female C57BL/6J 
mice at 8 weeks of age were treated with Buffer EL (Qiagen) to remove red blood cells, and cultured 
for more than 7 days with DMEM containing 10% FCS supplemented with 5% supernatant of CMG14-
12 cells producing mouse M-CSF (Takeshita et al., 2000). For thioglycollate-elicited peritoneal macro-
phages (thio-pMacs), mice were injected i.p. with 3% thioglycollate (Sigma). Peritoneal excudate cells 
were obtained 4 days later, and cultured in DMEM containing 10% FCS. For resident peritoneal 
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macrophages (rpMacs), mouse peritoneal cells were cultured at 37°C for 2 hr in RPMI1640 containing 
10% FCS on 12-well plates. Adherent cells were washed once with fresh medium, and used as rpMac.
Treatment of macrophages with apoptotic cells or cell supernatant
W3 cells were treated at 2 × 106 cells/ml with human FasL at 37°C for 30 min, washed, re-suspended 
at a concentration of 1 × 107 cells/ml with RPMI containing 1% FCS, and further incubated for 60 min 
at 37°C. At this stage, 94% cells were Annexin V-positive and PI-negative. The same treatment without 
FasL generated about 3% Annexin V-positive cells. The culture supernatant of W3 cells was recovered, 
0.5 ml-aliquots were added to mouse BMDMs (2 × 105 cells) or thio-pMacs (5 × 105 cells) in a 12-well 
microtiter plate. To study the effect of apoptotic cells, the FasL-treated W3 cells (5 × 106) were washed, 
re-suspended in RPMI containing 1% FCS at a concentration of 1 × 107 cells/ml, and added to BMDMs. 
After incubation at 37°C for 1 hr, the macrophages were washed with PBS, and total RNA for RT-PCR 
was prepared by using RNeasy mini kit (Qiagen). To study the effect of zymosan on the gene expression, 
rpMacs (6 × 105 cells) in a 12-well plate were treated with 50 μg/ml of zymosan and 100 μM AMP for 16 hr.
The fractionation of the supernatant of apoptotic W3 cells was carried out with a 10 kDa cutoff 
(MWCO) ultrafilter (Amicon Ultra, Millipore).
Microarray analysis, real time RT-PCR, and ELISA
For microarray analysis, RNA was amplified and labeled using GeneChip 3’ IVT Express Kit (Affymetrix, 
Santa Clare, CA), and the labeled probe was used for hybridization to a Mouse Genome 430 2.0 Array 
GeneChip (Affymetrix). The hybridized signals were detected with an Affymetrix Agilent Microarray 
scanner, and the array image was analyzed with Microarray Analysis Suit Version 5.0 (Affymetrix).
Real-time RT-PCR was performed with LightCycler 480 instrument (Roche, Indianapolis, IN) after 
total RNA was reverse transcribed by High Capacity RNA-to-cDNA kit (Applied Biosystems, Foster 
City, CA). Following primers were used: 5′-ATGCCTCCCCTACCAATCTTC-3′ and 5′-CACCAGTTCCT-
GGAACTTGGA-3′ for Nr4a1; 5′-TCACCTCCGGTGAGTCTGATC-3′ and 5′-TGCTGGATATGTTGGG-
TATCATCT-3′ for Nr4a2; 5′-GGT GCTGCAGAATGTGAGGT-3′ and 5′-GCTGGAACCGTTCACCACGT-3′ 
for Thbs1; 5′-AGCAGGCATCTGA GGGCCCA-3′ and 5′-GAGAGCAATGCCAGCCCCGG -3′ for 
Gapdh; 5′-TGTTACCAACTGGGACGACA-3′ and 5′-CCATCACAATGCCTGTGGTA -3′ for β-actin; 
5′-CATTGGGCCACAGACCTACT-3′ and 5′-CAAGGG AGAGAATCCAGCAG-3′ for Adora1; 5′-CTCTT-
CTTCGCCTGCTTTGT-3′ and 5′-AATGACAGCACCC AGCAAAT-3′ for Adora2a; 5′-CCTTTGCCATC-
ACCATCAG-3′ and 5′-GTGTCCCAGTGACCAAACCT-3′ for Adora2b; 5′-TCAGCCTGCAAGTCAAGATG-3′ 
and 5′-CAGCAAAGGCCCAAGAATAG-3′ for Adora3; 5′-GCCAAGAGTGCTCGAGATTT-3′ and 5′-TTC-
AGGACGCCTGATTTGAT-3′ for Panx1; 5′-CAAGAAGG CCAAGACTGAGG-3′ and 5′-CAGGATGGTGAG-
AGGGTCAG-3′ for Panx2; 5′-CCTCAGCTCTGACC TGCTGT-3′ and 5′-GAGGAGTAAGAGGGCGTTCC-3′ 
for Panx3. The amount of specific mRNA was normalized to Gapdh or β-actin mRNA for each indi-
vidual sample.
TNFα and MIP-2 levels were measured by ELISA kit from BioLegend and R&D Systems, respectively, 
according to the manufacture’s instruction.
Identification of metabolites in the apoptotic cell supernatant
W3 cells (2 × 106 cells/ml) were treated with 30 units/ml human FasL for 30 min, washed, re-suspended 
at a concentration of 1 × 107 cells/ml in serum-free RPMI medium supplemented with ITS-X (insulin, 
transferrin and selenous acid; Invitrogen, Carlsbad, CA), and further incubated for 1 hr. The superna-
tant was subjected to LC-MS analysis in Kazusa DNA Research Institute (Japan), using an Agilent 
1200 liquid chromatography system (Agilent technologies, Santa Clare, CA) connected to a Finnigan 
LTQ Orbitrap XL mass spectrometer (Thermo Fisher Scientific, Waltham, MA). The chromatography 
was performed at a constant flow rate of 0.5 ml/min with 3–95% linear gradient of acetonitrile in 0.1% 
formic acid, using a TOSOH TSKgel ODS-100V column (TOSOH, Japan).
Data were analyzed according to a molecular formula calculation in following databases: 
ExactMassDB (http://webs2.kazusa.or.jp/mfsearcher/exmassdb/), KEGG (http://www.genome.jp/
kegg/), KNApSAcK (http://kanaya.naist.jp/KNApSAcK/), Flavonoid Viewer (http://www.metabolome.
jp/software/FlavonoidViewer/) and LipidMAPS (http://www.lipidmaps.org/).
Quantification of adenosine and adenine nucleotides by LC-MS
For quantification of extracellular or intracellular adenine nucleotides, W3 cells (1 × 107 cells/ml) 
or thymocytes (1 × 108 cells/ml) from 6- to 8-week-old mice were treated with 120 units/ml human 
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FasL at 37°C in RPMI containing 1% FCS. After centrifugation at 1700×g for 4 min, the supernatant of 
the thymocytes was extracted by chloroform and methanol to remove lipids and proteins, lyophilized 
and reconstituted with distilled water. The LC-MS analysis was performed using a LC-MS system 
(Alliance/ZQ-4000, Waters, Milford, MA). Samples were separated at 45°C with Cosmosil-PAQ column 
(2.0 mm × 250 mm; Nacalai) using 1–45% acetonitrile gradient at a flow rate of 0.2 ml/min, and com-
pounds were detected using negative electrospray ionization. The concentration of adenosine, AMP, 
ADP and ATP was determined by comparing the peak areas with those of standards. In some cases, 
adenine nucleotides were quantified by HPLC using a Gilson PLC2020 system equipped with a 
COSMOSIL-PAQ column (Nacalai). The HPLC was performed using acetonitrile gradient (1–45% ace-
tonitrile in 30 min) in the presence of 1 mM dihexyl ammonium acetate (Tokyo Chemical Industry, Japan) 
at a flow rate of 1 ml/min. ATP level was also quantified by luciferase assay system.
Transformation of mouse W3 cells with Pannexin 1-expression vector
A full-length cDNA for mouse Panx1 (GenBank accession number NM_019482.2) was prepared by 
RT-PCR from mouse BMDMs, and its authenticity was verified by DNA sequencing. The caspase-
recognition sequence, Asp-Ile-Ile-Asp, at amino acid position 375–378 in mouse Panx1 was mutated 
by recombinant PCR to Ala-Ile-Ile-Ala. The cDNA was Flag-tagged at the C-terminus, and introduced 
into the pMXs-puro retroviral vector (Kitamura et al., 2003). Human 293T cells were co-transfected 
with the pMXs-puro expression vector, together with pEF-gag-pol and pE-Ampho (Takara Bio). 2 days 
later, the amphotropic retrovirus in the culture medium was concentrated by centrifugation at 6000×g 
for 16 hr, and used to infect W3 cells in the presence of 10 μg/ml polybrene. Transformants were 
selected in medium containing 1.0 μg/ml puromycin. To confirm the expression of mouse Panx1, the 
cells were permeabilized with 0.3% saponin, and stained with FITC-conjugated anti-Flag M2 (Sigma), 
followed by a flow cytometry with FACSCalibur (BD Bioscience, San Jose, CA).
Zymosan-induced peritonitis
Zymosan-induced peritonitis was performed essentially as described (Cash et al., 2009). In brief, 
female mice (n = 5–10 per group) at 8–12 weeks of age were injected i.p. with zymosan A particles 
(250 mg/kg, 0.5 ml saline). Peritoneal lavage fluid was harvested with 5 ml PBS containing 1% FCS at 
2 or 6 hr after the injection. Cells and residual zymosan particles were removed by centrifugation at 
900×g for 4 min. Mice were grouped randomly, and studied without being blinded.
To detect apoptotic cells, peritoneal cells were suspended in PBS containing 2% FCS, incubated on 
ice with 1 mg/ml of biotinylated anti-Ly6B.2 (AbD Serotec, UK), followed by the incubation with 2 μg/ml 
PE-Cy7-labeled streptavidin (BD Pharmingen) and 5 μg/ml FITC-labeled anti-Ly6G (1A8; BD Pharmingen). 
After washing with Annexin V binding buffer, cells were stained with 2000-fold diluted Cy5-labeled 
AnnexinV (Biovision, Milpitas, CA) and 500 nM Sytox blue (Invitrogen) and analyzed by flow cytometry.
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